161 related articles for article (PubMed ID: 19094510)
1. [Pathological manifestation and feasibility of conservative breast surgery after effective neoadjuvant chemotherapy for breast cancer].
Liu CP; Shi L; Li Z
Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(18):1394-6. PubMed ID: 19094510
[TBL] [Abstract][Full Text] [Related]
2. [Feasibility of breast conservation surgery after neoadjuvant chemotherapy for breast cancer].
Zhou B; Yang DQ; Qiao XM; Tong FZ; Cao YM; Liu P; Liu HJ
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):769-72. PubMed ID: 15949385
[TBL] [Abstract][Full Text] [Related]
3. [Neoadjuvant chemotherapy in the treatment of breast cancer. Results and prospectives].
Marzetti L; Framarino Dei Malatesta M; Yacoub M; Veneziano M; Bandiera AF; Fiorelli C; Felici A
Minerva Ginecol; 1997 Sep; 49(9):393-7. PubMed ID: 9446073
[TBL] [Abstract][Full Text] [Related]
4. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score.
Huang EH; Strom EA; Perkins GH; Oh JL; Chen AM; Meric-Bernstam F; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):352-7. PubMed ID: 16887286
[TBL] [Abstract][Full Text] [Related]
5. Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer.
Peintinger F; Kuerer HM; McGuire SE; Bassett R; Pusztai L; Symmans WF
Br J Surg; 2008 Apr; 95(4):433-7. PubMed ID: 18161887
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.
Rouzier R; Pusztai L; Garbay JR; Delaloge S; Hunt KK; Hortobagyi GN; Berry D; Kuerer HM
Cancer; 2006 Oct; 107(7):1459-66. PubMed ID: 16948128
[TBL] [Abstract][Full Text] [Related]
7. [The place of conservative surgery in the complex oncologic treatment of breast cancer].
Burcoş T; Popa E; Zodieru I; Bordea A; Voiculescu S; Angelescu N
Chirurgia (Bucur); 2003; 98(2):109-18. PubMed ID: 14992131
[TBL] [Abstract][Full Text] [Related]
8. [Breast carcinoma in the elderly].
Amodeo C; Caglià P; Gandolfo L; Cardillo P; Veroux M
Ann Ital Chir; 2002; 73(5):505-8; discussion 508-9. PubMed ID: 12704991
[TBL] [Abstract][Full Text] [Related]
9. Axillary-conserving surgery is facilitated by neoadjuvant chemotherapy of breast cancer.
Beatty JD; Precht LM; Lowe K; Atwood M
Am J Surg; 2009 May; 197(5):637-41; discussion 641-2. PubMed ID: 19321159
[TBL] [Abstract][Full Text] [Related]
10. Incidence of pathologic complete response in women treated with preoperative chemotherapy for locally advanced breast cancer: correlation of histology, hormone receptor status, Her2/Neu, and gross pathologic findings.
Alvarado-Cabrero I; Alderete-Vázquez G; Quintal-Ramírez M; Patiño M; Ruíz E
Ann Diagn Pathol; 2009 Jun; 13(3):151-7. PubMed ID: 19433292
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].
Straver ME; van Adrichem JC; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Gilhuijs KG; Oldenburg HS; Wesseling J; Russell NS; Antonini N; Vrancken Peeters MT
Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2519-25. PubMed ID: 19055260
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of preoperative multidetector-row computed tomography in evaluating the extent of invasive lobular carcinoma in patients with or without neoadjuvant chemotherapy.
Shien T; Akashi-Tanaka S; Yoshida M; Hojo T; Iwamoto E; Miyagawa K; Kinoshita T
Breast Cancer; 2009; 16(1):30-6. PubMed ID: 18360805
[TBL] [Abstract][Full Text] [Related]
13. Extramedullary hematopoiesis in breast after neoadjuvant chemotherapy for breast carcinoma.
Wang J; Darvishian F
Ann Clin Lab Sci; 2006; 36(4):475-8. PubMed ID: 17127738
[TBL] [Abstract][Full Text] [Related]
14. How do we measure a residual tumor size in histopathology (the gold standard) after neoadjuvant chemotherapy?
Apple SK; Suthar F
Breast; 2006 Jun; 15(3):370-6. PubMed ID: 16185870
[TBL] [Abstract][Full Text] [Related]
15. Breast conservation after neoadjuvant chemotherapy.
Sadetzki S; Oberman B; Zipple D; Kaufman B; Rizel S; Novikov I; Papa MZ
Ann Surg Oncol; 2005 Jun; 12(6):480-7. PubMed ID: 15868065
[TBL] [Abstract][Full Text] [Related]
16. [Side effects of adjuvant chemotherapy and radiotherapy concurrently after conservative surgery for breast cancer].
Liu P; Yang DQ; Qiao XM; Cao YM; Liu HJ; Wang S; Cheng L
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):854-6. PubMed ID: 16681980
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy.
Rosen EL; Blackwell KL; Baker JA; Soo MS; Bentley RC; Yu D; Samulski TV; Dewhirst MW
AJR Am J Roentgenol; 2003 Nov; 181(5):1275-82. PubMed ID: 14573420
[TBL] [Abstract][Full Text] [Related]
18. Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy.
Gómez-Iturriaga A; Pina L; Cambeiro M; Martínez-Regueira F; Aramendía JM; Fernández-Hidalgo O; Martínez-Monge R
Brachytherapy; 2008; 7(4):310-5. PubMed ID: 18778971
[TBL] [Abstract][Full Text] [Related]
19. Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual disease.
Rabban JT; Glidden D; Kwan ML; Chen YY
Am J Surg Pathol; 2009 Feb; 33(2):256-63. PubMed ID: 18936689
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions.
Mathew J; Asgeirsson KS; Cheung KL; Chan S; Dahda A; Robertson JF
Eur J Surg Oncol; 2009 Feb; 35(2):113-22. PubMed ID: 18502088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]